Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2011Journal of Zoo and Wildlife Medicine

Vaccination of Llamas, Llama glama, with an Experimental Killed Encephalomyocarditis Virus Vaccine

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does an experimental killed EMCV vaccine increase serum antibody titers in llamas?

Population

11 llamas (Llama glama)

Design

Preclinical

Follow-up

12 months

Authors

JKJennifer J. KilburnUniversity of TulsaDMDavid MurphyUniversity College CorkMTMark TitusOklahoma State University Medical Center

Discussion

Loading...

Member takes

Implication

May support immunogenicity testing in camelids; leaves open efficacy against clinical EMCV disease.

Structured PICO

Does an experimental killed EMCV vaccine increase serum antibody titers in llamas?

P
Population
11 llamas (Llama glama)
I
Intervention
Experimental killed Encephalomyocarditis virus (EMCV) vaccine, given as an initial vaccination and a second booster 4 weeks later
O
Outcome
Serum antibody responses to EMCV at 4 weeks, 8 weeks, 6 months, and 12 months postvaccinationsurrogate

An experimental killed EMCV vaccine safely induces a sustained antibody response in llamas for at least 12 months.

Cite This Study

Kilburn et al. (2011) studied this question.

synapsesocial.com/papers/6a8c0684d5d4290f64f495a2https://doi.org/10.1638/2010-0057.1
View Full Paper
Ask AI
Bookmark
Share